{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:09:23Z","timestamp":1793948963047,"version":"4.8.0"},"reference-count":70,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T00:00:00Z","timestamp":1261612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:p>\n                    <jats:bold>Background and purpose:\u2002<\/jats:bold>\n                    Apremilast is an orally administered phosphodiesterase\u20104 inhibitor, currently in phase 2 clinical studies of psoriasis and other chronic inflammatory diseases. The inhibitory effects of apremilast on pro\u2010inflammatory responses of human primary peripheral blood mononuclear cells (PBMC), polymorphonuclear cells, natural killer (NK) cells and epidermal keratinocytes were explored\n                    <jats:italic>in vitro<\/jats:italic>\n                    , and in a preclinical model of psoriasis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Experimental approach:\u2002<\/jats:bold>\n                    Apremilast was tested\n                    <jats:italic>in vitro<\/jats:italic>\n                    against endotoxin\u2010 and superantigen\u2010stimulated PBMC, bacterial peptide and zymosan\u2010stimulated polymorphonuclear cells, immunonoglobulin and cytokine\u2010stimulated NK cells, and ultraviolet B light\u2010activated keratinocytes. Apremilast was orally administered to beige\u2010severe combined immunodeficient mice, xenotransplanted with normal human skin and triggered with human psoriatic NK cells. Epidermal skin thickness, proliferation index and inflammation markers were analysed.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Key results:\u2002<\/jats:bold>\n                    Apremilast inhibited PBMC production of the chemokines CXCL9 and CXCL10, cytokines interferon\u2010\u03b3 and tumour necrosis factor (TNF)\u2010\u03b1, and interleukins (IL)\u20102, IL\u201012 and IL\u201023. Production of TNF\u2010\u03b1 by NK cells and keratinocytes was also inhibited.\n                    <jats:italic>In vivo<\/jats:italic>\n                    , apremilast significantly reduced epidermal thickness and proliferation, decreased the general histopathological appearance of psoriasiform features and reduced expression of TNF\u2010\u03b1, human leukocyte antigen\u2010DR and intercellular adhesion molecule\u20101 in the lesioned skin.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions and implications:\u2002<\/jats:bold>\n                    Apremilast displayed a broad pattern of anti\u2010inflammatory activity in a variety of cell types and decreased the incidence and severity of a psoriasiform response\n                    <jats:italic>in vivo.<\/jats:italic>\n                    Inhibition of TNF\u2010\u03b1, IL\u201012 and IL\u201023 production, as well as NK and keratinocyte responses by this phosphodiesterase\u20104 inhibitor suggests a novel approach to the treatment of psoriasis.\n                  <\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00559.x","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T05:42:33Z","timestamp":1261633353000},"page":"842-855","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":373,"title":["Apremilast, a cAMP phosphodiesterase\u20104 inhibitor, demonstrates anti\u2010inflammatory activity\n                    <i>in vitro<\/i>\n                    and in a model of psoriasis"],"prefix":"10.1111","volume":"159","author":[{"given":"PH","family":"Schafer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Parton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AK","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JB","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Loveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gilhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y\u2010F","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GS","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MD","family":"Houslay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u2010W","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GW","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DI","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2,23]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701723"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00749.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2005.01.003"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00384.2003"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.12010221"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.2.1065"},{"issue":"2","key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj3280539","article-title":"Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP\u2010specific phosphodiesterase PDE4D gene","volume":"328","author":"Bolger GB","year":"1997","journal-title":"Biochem J"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06645.x"},{"issue":"3","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2340\/0001555575218221","article-title":"In vitro T cell response to staphylococcal enterotoxin B superantigen in chronic plaque type psoriasis","volume":"75","author":"Bour H","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1689"},{"issue":"8","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-002-0349-4","article-title":"Natural killer and natural killer\u2010T cells in psoriasis","volume":"294","author":"Cameron AL","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969090-00001"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.064691"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.6.2466"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.76.060305.150444"},{"issue":"1","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4049\/jimmunol.154.1.308","article-title":"Inhibition of chemotactic peptide\u2010induced neutrophil adhesion to vascular endothelium by cAMP modulators","volume":"154","author":"Derian CK","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.12.059"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290135"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.297"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01812.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1607"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.4.2721"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X301866"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12297888"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03622-6"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000261934.56938.38"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.49.31334"},{"issue":"2","key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/bj3280549","article-title":"Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP\u2010specific phosphodiesterase, HSPDE4B3","volume":"328","author":"Huston E","year":"1997","journal-title":"Biochem J"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0340504"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.01.002"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.9.1489"},{"issue":"5","key":"e_1_2_8_33_1","first-page":"518","article-title":"Apremilast","volume":"6","author":"Khobzaoui M","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17708-3"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00082.x"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj3040399"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05663"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M414316200"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.1.318"},{"issue":"2","key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj3470571","article-title":"Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP\u2010response\u2010element\u2010binding protein (CREB) and p38 mitogen\u2010activated protein (MAP) kinase in U937 monocytic cells","volume":"347","author":"MacKenzie SJ","year":"2000","journal-title":"Biochem J"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704743"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1159\/000029821"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm900210d"},{"issue":"3","key":"e_1_2_8_44_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/bj1950645","article-title":"Purification and properties of the insulin\u2010stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes","volume":"195","author":"Marchmont RJ","year":"1981","journal-title":"Biochem J"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H049"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.11.013"},{"issue":"6","key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.154.6.2668","article-title":"Psoriatic skin\u2010derived dendritic cell function is inhibited by exogenous IL\u201010. Differential modulation of B7\u20101 (CD80) and B7\u20102 (CD86) expression","volume":"154","author":"Mitra RS","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(98)00475-2"},{"issue":"3","key":"e_1_2_8_49_1","first-page":"580","article-title":"Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model","volume":"146","author":"Nickoloff BJ","year":"1995","journal-title":"Am J Pathol"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535243"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0898-6568(97)00072-7"},{"key":"e_1_2_8_52_1","unstructured":"PappK BolducC RohaneP SutherlandD JonesM HuAet\u2003al.(2008).A Phase 2 Study Demonstrating the Efficacy and Safety of the Oral Therapy CC\u201010004 in Subjects with Moderate\u2010to\u2010Severe Psoriasis. 66th Annual AAD Meeting San Antonio Texas Feb 1\u20135."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.11.5450"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.04.043"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012292703871"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6468(08)00202-6"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00174752"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.11.029"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02737835"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705770"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.307"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12531617"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00021.2003"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb13073.x"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12313330"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200605050"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.090837"},{"key":"e_1_2_8_68_1","first-page":"215","article-title":"Rolipram inhibition of the human cyclic AMP specific phosphodiesterase splice variant PDE4D3 expressed in yeast","volume":"9","author":"Wilkinson I","year":"1997","journal-title":"Pharmacol Revs Commun"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706765200"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118989"},{"issue":"2","key":"e_1_2_8_71_1","first-page":"119","article-title":"Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats","volume":"7","author":"Yao W","year":"2007","journal-title":"J Musculoskelet Neuronal Interact"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00559.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:19:58Z","timestamp":1694636398000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00559.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00559.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00559.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719848696.793517124","asserted-by":"object"}]},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"2010-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}